Navigation Links
Biocartis Strengthens Management Team With Chief Commercial Officer

LAUSANNE, Switzerland and MECHELEN, Belgium, September 4, 2013 /PRNewswire/ --

Biocartis, a molecular diagnostics company, announces today that Ulrik Cordes has joined the company as Chief Commercial Officer (CCO). Ulrik Cordes is an executive with 18+ years of experience in marketing and sales in the med-tech, pharma and biotech industry, of which the past 10 years in top level management roles.

"We are delighted to welcome Ulrik to Biocartis' Executive Team," said RudiPauwels, CEO and Chairman  of Biocartis. "We are transforming from a development company into a commercial business. The addition of Ulrik will be key to achieving our ultimate goal to making personalized medicine a day-to- day reality by building a global business. Ulrik possesses a unique combination of experience and success in building winning commercial strategies and attracting world class sales and sales support professionals."

Ulrik Cordes joins Biocartis most recently from Thermo Fisher Scientific, where he held the position of Global Sales & Marketing Director Slides & Specialty Glass since March 2012. Since 2002 Ulrik worked at DAKO A/S - A World-leading Company in Cancer Diagnostics, where he held a number of positions with increasing responsibility, most recently as Vice President Marketing Operations and Vice President Asia Pacific & Export Region.

He started his career in 1995 in Pharmacia Biotech A/S (now part of GE Healthcare). Ulrik received his Master of Science in Biochemistry from the University of Copenhagen and holds a Bachelor of Commerce (HD) from Copenhagen Business School.

About Biocartis (
Biocartis aims to improve healthcare outcomes by enabling the practice of personalized medicine anywhere, anytime. Biocartis' ambition is to establish a new gold standard in diagnostic testing. Biocartis' innovative research and diagnostic systems are characterized by multiplex detection and simplified workflows which require less hands-on time and minimize sample requirements (especially for tumor biopsies). Additionally, Biocartis develops assays which have high clinical utility and compelling health economic value. Oncology is the primary focus of Biocartis as this is one of the greatest unmet needs for personalized medicine. Biocartis is well suited to address the growing need for individualized diagnosis and treatment of cancer patients.

Biocartis is a rapidly growing company; to date Biocartis staff includes over 170 people.

SOURCE Biocartis NV
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Biocartis versterkt managementteam met commercieel directeur
2. CareFusion Strengthens U.K. Presence With Acquisition of Medical Products Distributor
3. Tris Pharma Expands Manufacturing Capacity and Strengthens Supply Chain to Support New and Pending Approvals
4. RxAlly Strengthens Leadership Team With New Chief Information Officer Mike Groh
5. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
6. Actinium Pharmaceuticals Strengthens Management Team
7. Pharmalink AB Strengthens Senior Management Team
8. Jardogs Strengthens Leadership Team with the Addition of Two Seasoned Healthcare Executives
9. inVentiv Health Strengthens Clinical Leadership Team
10. Alliqua Strengthens and Realigns Executive Team
11. Neuland Labs Strengthens Commitment to Japanese Market With New Manufacturing Collaboration With Mitsubishi Healthcare Unit API Corporation
Post Your Comments:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... June 23, 2016 Revolutionary technology ... Oticon , industry leaders in advanced audiology and ... Oticon Opn ™, the world,s first internet connected ... for IoT devices.      (Photo: ... a number of ,world firsts,: , TwinLink™ ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):